Sanofi (SNY)
Sanofi Gross Profit Margin: 69.38%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNY Gross Profit Margin Rankings
| Overall | 76th percentile | 902 of 3914 |
| Sector | 69th percentile | 114 of 368 in Healthcare |
| Industry | 52nd percentile | 8 of 17 in Drug Manufacturers - Major |
SNY Gross Profit Margin Range, Past 5 Years
| Minimum | 66.00% | Jun 2011 |
| Maximum | 75.15% | Jun 2010 |
| Average | 70.85% |
About Gross Profit Margin
Gross profit margin is the difference between sales and the cost of goods sold divided by revenue. It expresses the relationship between gross profit (sales - cost of goods sold) and sales revenue. More specifically, gross profit margin represents the percentage of each dollar of a company's revenue that is available to cover fixed costs after paying for the goods or services that were sold.
If a company produces widgets and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32m - $24m)/$32m = %25.
Learn More
You may also be interested in these SNY related companies
SNY News
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
May 25, 2:01PM Street Insider
May 25, 2:01PM Street Insider
Mylan (MYL) Unit Launches Generic Version of Sanofi-Aventis' (SNY) Plavix
May 17, 1:42PM Street Insider
May 17, 1:42PM Street Insider
SPDR S&P 500 ETF and Bank of America Among Most Active Stocks in Pre-Market Today on the NYSE
May 17, 9:36AM Minyanville
May 17, 9:36AM Minyanville
$SNY why all the call interest today? Todays most active Options Sanofi 99.6% calls wow... http://stks.co/3qwq
about 10 days ago by justfurkids
about 10 days ago by justfurkids
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 11 days ago by abubnic
about 11 days ago by abubnic
5 Top International Dividend Stocks http://stks.co/3kyJ $SNY $CRH $ABB $SID $CS
about 17 days ago by myplaniq
about 17 days ago by myplaniq
$SNY - Closed out at the Initial Stop of $35.62 - http://stks.co/3kS9
about 17 days ago by TraderFoxxx
about 17 days ago by TraderFoxxx
Sanofi's (SNY) Genzyme Gets EMA, FDA Approval for Second Suite at Irish Plant
May 03, 7:37AM Street Insider
May 03, 7:37AM Street Insider
Genzyme Announces Regulatory Approvals of Expanded Waterford, Ireland Manufacturing Plant
May 03, 1:00AM Business Wire
May 03, 1:00AM Business Wire
Sanofi iBGStar® Blood Glucose Monitoring System Now Available in the U.S.
May 02, 8:00AM PR Newswire
May 02, 8:00AM PR Newswire
Sanofi-Aventis's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Apr 27, 5:45PM Seeking Alpha
Apr 27, 5:45PM Seeking Alpha
Emerging market push and Genzyme acquisition paying dividends for $SNY 9.9% sales growth significantly outperforming rivals $GSK and $AZN
about 29 days ago by sld1986
about 29 days ago by sld1986
Call $SNY "Stk revalues due to change in biz mix, geo. mix, and lack of patent exposure past '12" http://stks.co/3QzB $PFE $MRK $GSK
about 36 days ago by SumZero
about 36 days ago by SumZero
Quick Pitch: Long on $AZN Target Price: $62 http://stks.co/3Jz7 $SNY $NVS "Best downside protection among Pharma large caps"
about 44 days ago by SumZero
about 44 days ago by SumZero
$AAPL 3D camera patent in works. Who will get the nod as supplier? Either/or/both? $OVTI $SNY >> http://stks.co/3CBy
about 54 days ago by IncrementalWealth
about 54 days ago by IncrementalWealth
Trade Signal-New $SNY -BTO @ 38.08 Limit w/35.62 Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/pygmwen
about 75 days ago by TraderFoxxx
about 75 days ago by TraderFoxxx
News related to $SNY, currently +0.1% since open: 'FDA links once-promising pain drugs to bone decay' http://stks.co/2jWz
about 79 days ago by TradeBot
about 79 days ago by TradeBot
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNY | 34.31 | +0.08 | +0.23% | 92.01B |
| SNPS | 29.89 | +0.04 | +0.13% | 4.358B |
| SNP | 90.85 | +0.14 | +0.15% | 86.14B |
| SNMX | 2.33 | -0.04 | -1.69% | 92.66M |
| SNH | 20.78 | -0.03 | -0.14% | 3.380B |
| SNE | 13.30 | -0.46 | -3.34% | 13.35B |
| SNCR | 17.85 | -0.05 | -0.28% | 687.58M |
| SMTC | 24.08 | +0.38 | +1.60% | 1.575B |
| SMSC | 36.55 | -0.02 | -0.05% | 812.51M |
| SMS | 10.81 | -1.05 | -8.85% | 2.225B |